European Journal of Gynaecological Oncology
Print ISSN: 0392-2936 | Online ISSN: 2709-0086
European Journal of Gynaecological Oncology (EJGO) is an international, peer-reviewed, open access journal. EJGO publishes on a broad range of gynaecologic oncology topics. Different types of articles are considered for publication (see Aims & Scope) with emphasis on original research to include prospective clinical trials, basic and applied science, case-control, and cohort studies. We also encourage the submission of systematic reviews and meta-analyses.
Articles
Potential targeted therapies for ovarian cancer beyond PARP inhibitors
Potential targeted therapies for ovarian cancer beyond PARP inhibitors
DOI: 10.22514/ejgo.2025.030
Research progress in traditional Chinese medicine for the prevention and treatment of lower limb lymphedema after cervical cancer surgery/radiotherapy
Research progress in traditional Chinese medicine for the prevention and treatment of lower limb lymphedema after cervical cancer surgery/radiotherapy
DOI: 10.22514/ejgo.2025.031
The role of γH2AX and H2AX in cervical carcinogenesis, invasion, and metastasis, and their relationship with the expression of E-cadherin
The role of γH2AX and H2AX in cervical carcinogenesis, invasion, and metastasis, and their relationship with the expression of E-cadherin
DOI: 10.22514/ejgo.2025.032
Association of ultrasound findings with hematological parameters, cytokines and survival in ovarian cancer
Association of ultrasound findings with hematological parameters, cytokines and survival in ovarian cancer
DOI: 10.22514/ejgo.2025.033
Development and validation of a novel gene signatures based on a random forest algorithm and artificial neural network for predictive diagnosis of cervical squamous cell carcinoma
Development and validation of a novel gene signatures based on a random forest algorithm and artificial neural network for predictive diagnosis of cervical squamous cell carcinoma
DOI: 10.22514/ejgo.2025.034
ERG expression as a potential biomarker for endometrial carcinoma prognosis
ERG expression as a potential biomarker for endometrial carcinoma prognosis
DOI: 10.22514/ejgo.2025.035
Rates of dMMR status in endometrial hyperplasia in comparison to MMR related Lynch Syndrome of endometrial cancer: a pilot study
Rates of dMMR status in endometrial hyperplasia in comparison to MMR related Lynch Syndrome of endometrial cancer: a pilot study
DOI: 10.22514/ejgo.2025.036
Immunohistochemical expression and predictive value of PAX3 and FOXO1 proteins in high-grade serous ovarian carcinoma
Immunohistochemical expression and predictive value of PAX3 and FOXO1 proteins in high-grade serous ovarian carcinoma
DOI: 10.22514/ejgo.2025.038
Prediction of parametrial invasion of early cervical squamous cell carcinoma: combining apparent diffusion coefficient and greatest primary lesion dimension with hematological variables
Prediction of parametrial invasion of early cervical squamous cell carcinoma: combining apparent diffusion coefficient and greatest primary lesion dimension with hematological variables
DOI: 10.22514/ejgo.2025.039
Effect of case management based extended care model on mental state and quality of life of breast cancer patients
Effect of case management based extended care model on mental state and quality of life of breast cancer patients
DOI: 10.22514/ejgo.2025.040
Treatment of women with CIN3: LEEP versus hysterectomy—a retrospective study
Treatment of women with CIN3: LEEP versus hysterectomy—a retrospective study
DOI: 10.22514/ejgo.2025.041
Knockdown of NEIL3 inhibits the growth of breast cancer cells by mediating the PI3K/Akt/mTOR axis
Knockdown of NEIL3 inhibits the growth of breast cancer cells by mediating the PI3K/Akt/mTOR axis
DOI: 10.22514/ejgo.2025.042
Endometrial giant cell carcinoma: a case report and review of the literature
Endometrial giant cell carcinoma: a case report and review of the literature
DOI: 10.22514/ejgo.2025.043
Published Ahead of Print
Expression and clinical significance of CSAD in type I endometrial carcinoma
Expression and clinical significance of CSAD in type I endometrial carcinoma
Online publish date: 28 October 2024
DOI: 10.22514/ejgo.2024.110
Special Issues
Quality of Life in Gynecologic Malignancies
Keywords: Quality of life; Palliative care; Symptom management
Editor: Lori Spoozak, MD
Submission deadline: 31 December 2024
Endometrial Cancer and Fertility Preservation in the Denatality ERA
Keywords: Endometrial cancer; Fertility preservation; Surgery fertility sparing; Ovarian reserve
Editor: Dr. Giuseppe Gullo, MD, PhD,Dr. Alessandra Lopez, MD,Dr. Valentina Billone, MD, PhD St.
Submission deadline: 31 December 2025
Advances in Ovarian Cancer Research
Keywords: Ovarian cancer; Cytoreductive surgery; Recurrent ovarian cancer; Retroperitoneal lymphadenectomy; Women cancer global variation
Editor: Basel Refky, MD
Submission deadline: 31 July 2025
Current Update in the Treatment of Cervical Cancer
Keywords: Radical hysterectomy; Fertility Sparing; Oncological Outcomes
Editor: Carlo Ronsini, MD
Submission deadline: 31 December 2024
Gynecological Cancer Prevention: A New Prospective
Keywords: Gynecology; Obstetric and Gynecological Ultrasound; Menopause Obstetrics; Gynecologic Oncology; Gynecologic Pathology
Editor: Ottavia Dʼoria, MD
Submission deadline: 31 October 2023
Molecular Pathological Approach to Uterine Mesenchymal Tumors and Malignant Tumors for the Establishment of New Diagnostic and Therapeutic Methods
Keywords: Leiomyoma; Leiomyosarcoma; Ovarian cancer; Cervical cancer; Endometrial cancer
Editor: Prof. Takuma Hayashi
Submission deadline: 31 October 2023
Molecular Characterization in Endometrial Cancer: Progress and Prospects
Keywords: Endometrial Cancer (EC); Molecular Biomarkers; Immune Checkpoint Inhibitor; Precision Medicine
Editor: Andrea Giannini, MD, PhD
Submission deadline: 31 December 2022
Immunotherapy for Gynecological Oncology
Keywords: Cancer immunotherapy;Cancer vaccination;Immune checkpoint inhibitor;Ovarian cancer;Cervical cancer;Endometrial cancer
Editor: Tadahiro Shoji, MD
Submission deadline: 31 July 2021
Enhanced Recovery of Gynecological Oncology
Keywords: Gynecological Cancer; Enhanced Recovery After Surgery; Minimally Invasive Surgery; Pain Management; Nutritional Support; High Quality Nursing; Psychological Counseling; Complication Management
Editor: Lin Li, MD
Submission deadline: 31 December 2022
Molecular Markers in Ovarian Cancer: Roles in Diagnosis, Prognostic Prediction, and Personalized Therapy
Keywords: Ovarian Cancer;Diagnosis;Prognosis;Treatment Response;Personalized Therapy;Platinum Resistance;Homologous Recombination Deficiency;Immunotherapy;Cytoreduction;Proteomics;Genomics;Prognostic Biomarkers;Diagnostic Biomarkers
Editor: Sharad Ghamande, MD,David Mysona, MD
Submission deadline: 30 March 2022
Featured Article
Real-world bevacizumab utilization and outcomes among women with ovarian cancer in Europe and the United States. DOI: 10.31083/j.ejgo4206181
To Be a Reviewer
If you would like to volunteer to review a manuscript for European Journal of Gynaecological Oncology journal, please click “Review for EJGO” below to register at our submission website or log in our Online Peer Review system. Your name, contact details, and expertise will be automatically added to our database of reviewers.
Review for EJGOJoin Editorial Board
You are welcome to join our editorial board. Our journal produces and issues editorial board certificates for editorial board members, and the journal website will display the names and personal websites of editorial board members to help enhance their scientific influence. Members of the editorial committee are entitled to 1 free publication (both editorial member’s or recommended paper) per year, and other articles over 2 can enjoy 30% discount of publishing fee.
Join Editorial BoardEditor-in-Chief
Prof. Enrique Hernandez, MD, FACOG, FACS.
Dr. Hernandez is the J. Robert Willson Professor and Chair, Obstetrics, Gynecology and Reproductive Sciences of Lewis Katz School of Medicine at Temple University. He is also a professor in Pathology and Laboratory Medicine of Lewis Katz School of Medicine at Temple University. He specializes in comprehensive, compassionate care of women with gynecologic cancer and pre-cancerous conditions, using the most up-to-date and sophisticated diagnostic and treatment tools.